Setting the record straight about participation in clinical trials.
Most Recent Posts
“When compounded products are not made according to strict quality standards appropriate for their scale of production, the results can be deadly.” Six public health organizations wrote this to FDA Commissioner Hamburg to voice strong support on FDA’s robust enforcement of the federal law on compounding.
Researchers in biopharmaceutical companies strive to discover and develop new medicines and vaccines that will help people to live longer, healthier lives. They go to work every day knowing that patients with life-threatening diseases live with the hope that tomorrow will bring a new medicine that will extend and improve lives.
Following several years of modest growth, a new study published in Health Affairs reports a record low health care spending increase of 3.6 percent in 2013. The last time the annual growth rate was any smaller, Dwight Eisenhower was President and a gallon of milk cost 49 cents. The year was 1960.
Today is World AIDS Day, and we’re examining the tremendous progress we’ve made turning what was once considered a virtual death sentence into a chronic condition. The fact that the death rate for HIV/AIDS patients has decreased nearly 85 percent since its peak in the mid-1990s is a testament to the dedicated researchers who worked tirelessly to develop new medicines like those that make up highly active antiretroviral therapy (HAART) that transformed how we treated the disease.
Today, United States Trade Representative Michael Froman is in India to participate in the U.S. – India Trade Policy Forum. Since Indian Prime Minister Narendra Modi’s election in May, Indian and U.S. leaders have held several meetings to further the relationship between our countries
With Black Friday just a few days away, holiday shopping madness is kicking into full gear. Deciding what to buy, comparing prices and ultimately making a decision can be stressful. The best advice for Black Friday also applies to shopping for health insurance:Shop early Compare options Choose the best for you and your family
Every November is Diabetes Awareness Month – a time to reflect on the progress we have made in treating the nearly 26 million Americans with the chronic disease. We take stock of new treatments, awareness, better adherence to diabetes medications and ask ourselves, “what more can we do?” to better treat this serious public health concern.
Since 2000, biopharmaceutical companies have brought more than 450 new innovative medicines to the U.S. market, resulting in significant progress against some of the most costly and challenging diseases. Yet, prescription drug spending in the U.S. has remained constant and federal projections show growth is in-line with health care spending through the next decade.
November is National Lung Cancer Awareness Month, a time to reflect upon the disease’s enormous human cost. This month, some 18,600 Americans will be diagnosed with lung cancer and approximately 13,000 Americans will be killed by it. It is, by a wide margin, the most common cause of cancer death in the United States.
Patients are living longer, healthier lives thanks to biopharmaceutical innovation. But, as evidenced by a new study released yesterday by the Tufts Center for the Study of Drug Development, the road to bringing a new FDA-approved medicine to patients is long and the costs are formidable.
“Unless someone like you cares a whole awful lot, nothing is going to get better. It’s not.” Real change and progress, as Dr. Seuss suggests, starts with passionate individuals who want to make a difference. This is obvious from the dedicated researchers around the world working tirelessly to find new treatments that help patients with devastating diseases like gastrointestinal (GI) cancers.
The discovery and development of new medicines for patients is a comprehensive, data-driven process that requires years of research. At the heart of this endeavor is the clinical trial, the rigorous and highly-regulated scientific study of potential new medicines.